Glenn H. Dillon - Publications

Affiliations: 
Pharmacology and Neuroscience University of North Texas Health Science Center at Fort Worth 
Area:
Pharmacology, Neuroscience Biology

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Kumar M, Kumar M, Freund J, Dillon GH. A Single amino acid residue at transmembrane domain 4 of the alpha subunit influences carisoprodol direct gating efficacy at GABAA receptors. The Journal of Pharmacology and Experimental Therapeutics. PMID 28642232 DOI: 10.1124/Jpet.117.242156  0.566
2017 Huang R, Chen Z, Dolan S, Schetz JA, Dillon GH. The dual modulatory effects of efavirenz on GABAA receptors are mediated via two distinct sites. Neuropharmacology. PMID 28456686 DOI: 10.1016/J.Neuropharm.2017.04.038  0.709
2017 Chen Z, Liu R, Yang SH, Dillon GH, Huang R. Methylene blue inhibits GABAA receptors by interaction with GABA binding site. Neuropharmacology. PMID 28390894 DOI: 10.1016/J.Neuropharm.2017.04.002  0.705
2016 Kumar M, Dillon GH. Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABAA receptors. European Journal of Pharmacology. PMID 26872987 DOI: 10.1016/J.Ejphar.2016.02.031  0.681
2015 Kumar M, González LA, Dillon GH. Assessment of subunit-dependent direct gating and allosteric modulatory effects of carisoprodol at GABAA receptors. Neuropharmacology. PMID 25896767 DOI: 10.1016/J.Neuropharm.2015.04.007  0.822
2015 Kumar M, Dillon GH. Carisoprodol: Update on abuse potential and mechanism of action Molecular and Cellular Pharmacology. 7: 1-10. DOI: 10.4255/mcpharmacol.15.01  0.313
2013 Huang R, Griffin SA, Taylor M, Vangveravong S, Mach RH, Dillon GH, Luedtke RR. The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition. Pharmacology. 92: 84-9. PMID 23942137 DOI: 10.1159/000351971  0.471
2013 Gatch MB, Kozlenkov A, Huang RQ, Yang W, Nguyen JD, González-Maeso J, Rice KC, France CP, Dillon GH, Forster MJ, Schetz JA. The HIV antiretroviral drug efavirenz has LSD-like properties. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2373-84. PMID 23702798 DOI: 10.1038/Npp.2013.135  0.383
2012 Luedtke RR, Mishra Y, Wang Q, Griffin SA, Bell-Horner C, Taylor M, Vangveravong S, Dillon GH, Huang RQ, Reichert DE, Mach RH. Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds. Acs Chemical Neuroscience. 3: 1050-62. PMID 23259040 DOI: 10.1021/Cn300142Q  0.432
2010 Huang R, Singh M, Dillon GH. Genistein directly inhibits native and recombinant NMDA receptors. Neuropharmacology. 58: 1246-51. PMID 20303997 DOI: 10.1016/J.Neuropharm.2010.03.006  0.452
2009 Gonzalez LA, Gatch MB, Forster MJ, Dillon GH. Abuse Potential of Soma: the GABA(A) Receptor as a Target. Molecular and Cellular Pharmacology. 1: 180-186. PMID 20419052  0.753
2009 Gonzalez LA, Gatch MB, Taylor CM, Bell-Horner CL, Forster MJ, Dillon GH. Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies. The Journal of Pharmacology and Experimental Therapeutics. 329: 827-37. PMID 19244096 DOI: 10.1124/Jpet.109.151142  0.79
2009 Gonzalez LA, Gatch MB, Forster MJ, Dillon GH. Abuse potential of Soma®: The GABAA receptor as a target Molecular and Cellular Pharmacology. 1: 180-186. DOI: 10.4255/Mcpharmacol.09.21  0.705
2008 Sarkar SN, Huang RQ, Logan SM, Yi KD, Dillon GH, Simpkins JW. Estrogens directly potentiate neuronal L-type Ca2+ channels. Proceedings of the National Academy of Sciences of the United States of America. 105: 15148-53. PMID 18815371 DOI: 10.1073/Pnas.0802379105  0.315
2008 Tchedre KT, Huang RQ, Dibas A, Krishnamoorthy RR, Dillon GH, Yorio T. Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. Investigative Ophthalmology & Visual Science. 49: 4993-5002. PMID 18641291 DOI: 10.1167/Iovs.08-1867  0.478
2008 Gonzales EB, Bell-Horner CL, Dibas MI, Huang RQ, Dillon GH. Stoichiometric analysis of the TM2 6' phenylalanine mutation on desensitization in alpha1beta2 and alpha1beta2gamma2 GABA A receptors. Neuroscience Letters. 431: 184-9. PMID 18162311 DOI: 10.1016/J.Neulet.2007.11.039  0.779
2007 Huang R, He S, Chen Z, Dillon GH, Leidenheimer NJ. Mechanisms of homomeric alpha1 glycine receptor endocytosis. Biochemistry. 46: 11484-93. PMID 17887775 DOI: 10.1021/Bi701093J  0.617
2006 Bell-Horner CL, Dohi A, Nguyen Q, Dillon GH, Singh M. ERK/MAPK pathway regulates GABAA receptors. Journal of Neurobiology. 66: 1467-74. PMID 17013930 DOI: 10.1002/Neu.20327  0.625
2006 Chen Z, Dillon GH, Huang R. Identification of residues critical for Cu2+-mediated inhibition of glycine alpha1 receptors. Neuropharmacology. 51: 701-8. PMID 16842826 DOI: 10.1016/J.Neuropharm.2006.05.009  0.398
2006 Machu TK, Dillon GH, Huang R, Lovinger DM, Leidenheimer NJ. Temperature: an important experimental variable in studying PKC modulation of ligand-gated ion channels. Brain Research. 1086: 1-8. PMID 16626662 DOI: 10.1016/J.Brainres.2006.01.091  0.407
2005 Hayrapetyan V, Jenschke M, Dillon GH, Machu TK. Co-expression of the 5-HT(3B) subunit with the 5-HT(3A) receptor reduces alcohol sensitivity. Brain Research. Molecular Brain Research. 142: 146-50. PMID 16257471 DOI: 10.1016/J.Molbrainres.2005.09.011  0.384
2005 Das P, Dillon GH. Molecular determinants of picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors. The Journal of Pharmacology and Experimental Therapeutics. 314: 320-8. PMID 15814570 DOI: 10.1124/Jpet.104.080325  0.79
2005 Herring D, Huang R, Singh M, Dillon GH, Leidenheimer NJ. PKC modulation of GABAA receptor endocytosis and function is inhibited by mutation of a dileucine motif within the receptor beta 2 subunit. Neuropharmacology. 48: 181-94. PMID 15695157 DOI: 10.1016/J.Neuropharm.2004.09.015  0.667
2004 Gonzales EB, Dillon G. The Second Transmembrane Domain 7' Position Influences Channel Kinetics in the Glycine α1 Receptor. The Biological Bulletin. 207: 156. PMID 27690579 DOI: 10.1086/Bblv207N2P156  0.758
2004 Huang RQ, Chen Z, Dillon GH. Molecular basis for modulation of recombinant alpha1beta2gamma2 GABAA receptors by protons. Journal of Neurophysiology. 92: 883-94. PMID 15028749 DOI: 10.1152/Jn.01040.2003  0.703
2004 Das P, Bell-Horner CL, Huang RQ, Raut A, Gonzales EB, Chen ZL, Covey DF, Dillon GH. Inhibition of type A GABA receptors by L-type calcium channel blockers. Neuroscience. 124: 195-206. PMID 14960351 DOI: 10.1016/J.Neuroscience.2003.12.005  0.842
2004 Gonzales EB, Bell-Horner CL, de la Cruz MA, Ferrendelli JA, Covey DF, Dillon GH. Enantioselectivity of alpha-benzyl-alpha-methyl-gamma-butyrolactone-mediated modulation of anticonvulsant activity and GABA(A) receptor function. The Journal of Pharmacology and Experimental Therapeutics. 309: 677-83. PMID 14742738 DOI: 10.1124/Jpet.103.063008  0.818
2004 Chen Z, Dillon GH, Huang R. Molecular determinants of proton modulation of glycine receptors. The Journal of Biological Chemistry. 279: 876-83. PMID 14563849 DOI: 10.1074/Jbc.M307684200  0.596
2004 Luedtke RR, Bell-Horner CL, Volk M, Reinecke MG, Dillon GH. Pharmacological survey of medicinal plants for activity at ligand-gated ion channels: Selective interaction with 5-HT3 receptors Pharmaceutical Biology. 42: 73-82. DOI: 10.1080/13880200490505654  0.68
2003 Yagle MA, Martin MW, de Fiebre CM, de Fiebre NC, Drewe JA, Dillon GH. [3H]Ethynylbicycloorthobenzoate ([3H]EBOB) binding in recombinant GABAA receptors. Neurotoxicology. 24: 817-24. PMID 14637376 DOI: 10.1016/S0161-813X(03)00051-2  0.465
2003 Das P, Dillon GH. The 5-HT3B subunit confers reduced sensitivity to picrotoxin when co-expressed with the 5-HT3A receptor. Brain Research. Molecular Brain Research. 119: 207-12. PMID 14625088 DOI: 10.1016/J.Molbrainres.2003.09.003  0.734
2003 Herring D, Huang R, Singh M, Robinson LC, Dillon GH, Leidenheimer NJ. Constitutive GABAA receptor endocytosis is dynamin-mediated and dependent on a dileucine AP2 adaptin-binding motif within the beta 2 subunit of the receptor. The Journal of Biological Chemistry. 278: 24046-52. PMID 12707262 DOI: 10.1074/Jbc.M301420200  0.704
2003 Das P, Bell-Horner CL, Machu TK, Dillon GH. The GABA(A) receptor antagonist picrotoxin inhibits 5-hydroxytryptamine type 3A receptors. Neuropharmacology. 44: 431-8. PMID 12646280 DOI: 10.1016/S0028-3908(03)00032-7  0.745
2002 Huang RQ, Dillon GH. Functional characterization of GABA(A) receptors in neonatal hypothalamic brain slice. Journal of Neurophysiology. 88: 1655-63. PMID 12364495 DOI: 10.1152/Jn.2002.88.4.1655  0.654
2002 Dibas MI, Gonzales EB, Das P, Bell-Horner CL, Dillon GH. Identification of a novel residue within the second transmembrane domain that confers use-facilitated block by picrotoxin in glycine alpha 1 receptors. The Journal of Biological Chemistry. 277: 9112-7. PMID 11744711 DOI: 10.1074/Jbc.M111356200  0.782
2001 Huang RQ, Dillon GH. Functional analysis of GABAA receptors in nucleus tractus solitarius neurons from neonatal rats Brain Research. 921: 183-194. PMID 11720725 DOI: 10.1016/S0006-8993(01)03117-1  0.528
2001 Huang RQ, Bell-Horner CL, Dibas MI, Covey DF, Drewe JA, Dillon GH. Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. The Journal of Pharmacology and Experimental Therapeutics. 298: 986-95. PMID 11504794  0.836
2000 Huang RQ, Dillon GH. Direct inhibition of glycine receptors by genistein, a tyrosine kinase inhibitor Neuropharmacology. 39: 2195-2204. PMID 10963763 DOI: 10.1016/S0028-3908(00)00046-0  0.47
2000 Dibas MI, Dillon GH. The central nervous system convulsant pentylenetetrazole stimulates gamma-aminobutyric acid (GABA)-activated current in picrotoxin-resistant GABA(A) receptors in HEK293 cells. Neuroscience Letters. 285: 193-6. PMID 10806319 DOI: 10.1016/S0304-3940(00)01064-8  0.841
2000 Bell-Horner CL, Dibas M, Huang RQ, Drewe JA, Dillon GH. Influence of subunit configuration on the interaction of picrotoxin-site ligands with recombinant GABA(A) receptors Molecular Brain Research. 76: 47-55. PMID 10719214 DOI: 10.1016/S0169-328X(99)00330-7  0.836
1999 Huang RQ, Dillon GH. Effect of extracellular pH on GABA-activated current in rat recombinant receptors and thin hypothalamic slices Journal of Neurophysiology. 82: 1233-1243. PMID 10482743 DOI: 10.1152/Jn.1999.82.3.1233  0.588
1999 Huang RQ, Fang MJ, Dillon GH. The tyrosine kinase inhibitor genistein directly inhibits GABA(A) receptors Molecular Brain Research. 67: 177-183. PMID 10101245 DOI: 10.1016/S0169-328X(99)00061-3  0.615
1998 Huang RQ, Dillon GH. Maintenance of recombinant type a γ-aminobutyric acid receptor function: Role of protein tyrosine phosphorylation and calcineurin Journal of Pharmacology and Experimental Therapeutics. 286: 243-255. PMID 9655866  0.543
1995 Im WB, Binder JA, Dillon GH, Pregenzer JF, Im HK, Altman RA. Acceleration of GABA-dependent desensitization by mutating threonine 266 to alanine of the alpha 6 subunit of rat GABAA receptors. Neuroscience Letters. 186: 203-7. PMID 7777197 DOI: 10.1016/0304-3940(95)11293-6  0.596
1995 Im WB, Pregenzer JF, Binder JA, Dillon GH, Alberts GL. Chloride channel expression with the tandem construct of α6-β2 GABAA receptor subunit requires a monomeric subunit of α6 or γ2 Journal of Biological Chemistry. 270: 26063-26066. PMID 7592805  0.478
1995 Dillon GH, Im WB, Carter DB, McKinley DD. Enhancement by GABA of the association rate of picrotoxin and tert-butylbicyclophosphorothionate to the rat cloned α1β2γ2 GABA(A) receptor subtype British Journal of Pharmacology. 115: 539-545. PMID 7582470  0.594
1995 Dillon GH, Wha Bin Im, Pregenzer JF, Carter DB, Hamilton BJ. [4-Dimethyl-3-t-butylcarboxyl-4,5-dihydro (1,5-a) quinoxaline] is a novel ligand to the picrotoxin site on GABA(A) receptors, and decreases single- channel open probability Journal of Pharmacology and Experimental Therapeutics. 272: 597-603. PMID 7531762  0.54
1993 Dillon GH, Im HK, Hamilton BJ, Carter DB, Gammill RB, Judge TM, Wha Bin Im. U-93631 causes rapid decay of γ-aminobutyric acid-induced chloride currents in recombinant rat γ-aminobutyric acid type A receptors Molecular Pharmacology. 44: 860-865. PMID 8232235  0.582
1991 Dillon GH, Shonis CA, Waldrop TG. Hypothalamic GABAergic modulation of respiratory responses to baroreceptor stimulation Respiration Physiology. 85: 289-304. PMID 1961995 DOI: 10.1016/0034-5687(91)90069-U  0.354
Show low-probability matches.